CDD-0078
| CDD-0078 | |
|---|---|
| [[File:|frameless|220px|alt=|Chemical structure of CDD-0078]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
CDD-0078 is an investigational drug currently under development for the treatment of neurodegenerative diseases. It is a small molecule that has shown promise in preclinical studies for its potential to modulate specific pathways involved in neuronal survival and function.
Mechanism of Action
CDD-0078 is believed to exert its effects by targeting the protein kinase pathways that are crucial for cell survival and apoptosis. Specifically, it modulates the activity of kinase enzymes that are involved in the regulation of neurotrophic factors, which are essential for the growth, maintenance, and survival of neurons.
Pharmacokinetics
The pharmacokinetic profile of CDD-0078 is characterized by its high bioavailability and moderate half-life, allowing for once-daily dosing. It is primarily metabolized in the liver and excreted via the renal pathway. Studies have shown that CDD-0078 has a favorable safety profile with minimal adverse effects.
Clinical Trials
As of the latest updates, CDD-0078 is in Phase II clinical trials. These trials are focused on evaluating its efficacy and safety in patients with early-stage Alzheimer's disease. Preliminary results have indicated a potential improvement in cognitive function and a reduction in the progression of neurodegenerative symptoms.
Potential Applications
Beyond Alzheimer's disease, CDD-0078 is being explored for its potential use in other neurodegenerative conditions such as Parkinson's disease and Huntington's disease. Its ability to modulate neurotrophic pathways makes it a candidate for a broad range of neurological disorders.
Research and Development
The development of CDD-0078 is being spearheaded by a collaboration between academic institutions and pharmaceutical companies. Ongoing research is focused on optimizing its therapeutic effects and understanding its long-term impact on neuronal health.
Also see
- Neurodegenerative disease
- Alzheimer's disease
- Parkinson's disease
- Huntington's disease
- Protein kinase
- Neurotrophic factors
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
